The management of an ST elevation myocardial infarction has undergone significant changes in the past few years. Fibrinolytic agents have become more and more clot specific increasing their efficacy. However, percutaneous coronary intervention, along with its adjuvant therapy (glycoprotein IIB/IIIA receptor inhibitors and clopidrogel), have come to challenge fibrinolytic use. Many studies have demonstrated the benefits of percutaneous coronary intervention as compared to fibrinolysis in the management of acute myocardial infarction by decreasing infarct size, myocardial function loss, and mortality.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
percutaneous coronary
12
coronary intervention
12
myocardial infarction
12
management elevation
8
elevation myocardial
8
intervention versus
4
versus thrombolysis
4
thrombolysis definite
4
definite management
4
myocardial
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!